Heartflow, Inc. Common Stock

Heartflow, Inc. Common Stock

HTFL
Heartflow, Inc. Common StockUS flagNASDAQ Global Select
55.82
USD
+0.23
- -
4.85BMarket Cap
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.37
1.56
4.78
2.77
Basic EPS, GAAP
-1.94
-1.2
-3.17
-1.55
Free Cash Flow per Basic Share
-1.29
-0.91
-1.6
-0.77
Dividend per Share
- -
- -
- -
- -
Book Value per Share
-9.65
-10.66
3.53
3.23
Tangible Book Value per Share
-9.14
-10.11
3.53
3.23
Basic Weighted Avg Shares
64
81
37
76
Sales/Revenue/Turnover
87
126
176
212
Operating Margin (%)
-83.64
-48.66
-36.39
-34.31
Depreciation Expense
8
8
9
9
Net Income, GAAP
-96
-96
-117
-118
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
-109.73
-76.65
-66.35
-55.82
Working Capital
116
49
178
180
LT Debt
155
155
16
20
Total Equity
-778
-859
301
280
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
-98.5

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
6
6
7
LT Borrowings
- -
- -
- -
LT Finance Leases
16
20
20
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
85
86
87
Market Capitalization
2,486
2,095
2,544

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
220
212
224
Cash, Cash Equivalents & STI
177
158
163
Accounts Receivable, Net
29
36
43
Inventories
- -
- -
- -
Total Current Liabilities
42
38
44
Payables & Accruals
34
28
34
ST Debt
6
6
7
Deferred Revenue
1
2
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-134.98%
Free Cash Flow
- -
- -
-19.51%
Net Income, GAAP
- -
- -
21.12%
Sales/Revenue/Turnover
- -
- -
39.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
27
31
33
35
126
2025
37
43
46
49
176
2026
53
64
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.33
-0.37
-0.3
- -
-1.2
2025
-0.4
-0.11
-1.04
-0.29
-3.17
2026
-0.32
-0.18
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
John Farquhar
Full Time Employees
843
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
135 Main Street San Francisco CA United States of America 94105
IPO Date
Aug 7, 2025
Business
HeartFlow, Inc. is a medical technology firm that delivers advanced non-invasive solutions globally for the assessment and management of coronary artery disease. Through its HeartFlow Platform, the company leverages artificial intelligence and computational fluid dynamics to construct a unique three-dimensional cardiac model from a routine coronary computed tomography angiography, a specialized imaging technique that yields detailed visuals of the heart's vessels. This advanced platform offers critical insights into coronary blood flow, the degree of arterial narrowing (stenosis), and the characteristics of plaque, thereby enhancing diagnostic capabilities beyond conventional non-invasive assessments. These capabilities help clinicians identify the significance of blockages and avoid unnecessary invasive procedures. Established in 2007, the company maintains its headquarters in Mountain View, California.

Company News

  • Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026

  • Heartflow (NASDAQ:HTFL) Sets New 12-Month High – Should You Buy?

  • Vikram Verghese Sells 7,579 Shares of Heartflow (NASDAQ:HTFL) Stock

  • Heartflow (NASDAQ:HTFL) Reaches New 52-Week High – Still a Buy?

  • 12,278 Shares in Heartflow, Inc. $HTFL Bought by Amundi

  • John C.M. Farquhar Sells 35,010 Shares of Heartflow (NASDAQ:HTFL) Stock

  • HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High

  • Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysis

  • HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High

  • Baron SMID Cap ETF Q2 2026 Portfolio Activity

  • Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFL

  • BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFL

  • Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

  • Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

  • HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?

  • HeartFlow: An Impressive MedTech Growth Play

  • Why Heartflow Stock Soared Today

  • HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance

  • HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript

  • Heartflow Q2 Earnings Call Highlights